🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-label, prospective intervention study of IndoVac® as a single, homolog...
Status
Completed
Location
Faculty of Medicine Diponegoro University
Start Date
2023-07-25
Trial ID
NCT05933278
Treatments Being Tested
The success of the U.S. vaccination program against SARS-Cov-2 is shown by ...
Status
Terminated
Location
Griffin Hospital
Start Date
2021-10-15
Trial ID
NCT05081271
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
To evaluate the effectiveness of the single dose Ad26.COV2.S COVID-19 vacci...
Status
Unknown
Location
Nelson Mandela Academic Clinical Research Unit (NeMACRU)
Start Date
2021-11-10
Trial ID
NCT05148845
Treatments Being Tested
This is a retrospective test-negative case-control study of COVID-19 Vaccin...
Status
Unknown
Location
Instituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ)
Start Date
2022-07-30
Trial ID
NCT05367895
Treatments Being Tested
PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Status
Completed
Location
National Centre for Infectious Diseases (NCID)
Start Date
2021-10-12
Trial ID
NCT05142319
Treatments Being Tested
This is a randomized, phase II trial which will be conducted among voluntee...
Status
Unknown
Location
National Institute of Health
Start Date
2022-03-01
Trial ID
NCT05162482
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, dose-escalation s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05609045
Treatments Being Tested
This is a multicenter, open-label, partially radomized, parallel-controlled...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2022-01-22
Trial ID
NCT05204589
Treatments Being Tested
This Phase 2, randomized, observer-blind clinical study is evaluating 3 dif...
Status
Completed
Location
Cullman Clinical Trials
Start Date
2023-06-07
Trial ID
NCT05874713
Treatments Being Tested